Literature DB >> 2445086

Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

S Thiru1, D S Collier, R Calne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445086

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  18 in total

1.  Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors:  A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

2.  Pathologic observations in human allograft recipients treated with FK 506.

Authors:  A J Demetris; J J Fung; S Todo; B Banner; T Zerbe; G Sysyn; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.

Authors:  Y Kang; M A Mazer; A M DeWolf; J J Fung; T Gasior; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  The effects of FK 506 on renal function after liver transplantation.

Authors:  J McCauley; J Fung; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

5.  In vivo 31P nuclear magnetic resonance findings on heterotopically allografted hearts in rats treated with a novel immunosuppressant, FK506.

Authors:  S Suzuki; M Kanashiro; R Hayashi; T Kenmochi; T Fukuoka; H Amemiya
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

6.  Effect of FK 506 on glucose metabolism and insulin secretion in normal rats.

Authors:  W J Tze; J Tai; N Murase; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  FK 506 inhibits the development of transplant arteriosclerosis.

Authors:  G D Wu; D V Cramer; F A Chapman; E Cajulis; H K Wang; T E Starzl; L Makowka
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  Inhibition by FK506 of established lesions of collagen-induced arthritis in rats.

Authors:  C Arita; T Hotokebuchi; H Miyahara; K Arai; Y Sugioka; N Kaibara
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

9.  Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.

Authors:  K Abu-Elmagd; S Todo; J Fung; J Demetris; J Rakela; A S Rao; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1994

10.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.